8.900
+0,00%
2026-10-16
Fundamental Analysis
20 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -116.2% | -124.6% | 0 / 3 | -46.5% | +3.06 pp | -8.39 pp | +2.0% | 1.47 | 30.96 | 25,1 | −46,5% | −0,5 | −116,2% | 30.96 | 7.33 | +322,3% |
| Pts | 0 | 0 | 0 | 0 | 12 | 0 | 0 | 6 | 4 | |||||||
Valuation annotation:Price: 8.900 (close price on 2026-10-16)EPS (TTM): 287,5
Financial charts
1.Revenue & growth
VND bn25,1Q3/26
1.Revenue & growth
VND bn25,1Q3/26
2.Profit & growth
VND bn-0,49Q3/26
3.Profit mix (Penman)
VND bn2,33Q3/26
4.Margins & cost structure
%9.9%Q3/26
5.Returns & cash cycle
% · days1.5%Q3/26
6.Earnings quality & cash
VND bn-5,48Q3/26
7.Asset structure
VND bn173Q3/26
8.Funding & debt health
VND bn · times173Q3/26
9.Revenue backlog
VND bn3,36Q3/26
10.Valuation
times · %34,3×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-96Q3/26
Adjusted EPS growth, latest quarter
-116%
Average adjusted EPS growth, 3 quarters
-126%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q3/26